Facebook
Twitter
LinkedIn
Forward
Courage and Innovation Symposium 2024
Chicago, IL US
February 24, 2024
Enhance Your Cardiovascular Expertise at Our Cutting-Edge Educational Symposium!
Join us for an immersive educational symposium that will empower you to harness the latest innovations in cardiovascular disease therapies. Our distinguished faculty boasts leading clinicians from the renowned University of Chicago Heart and Vascular Center, as well as internationally recognized guest experts.
This event is designed to be a dynamic learning experience. Through engaging didactic sessions, interactive panel discussions, illuminating case studies, and collaborative dialogue, you'll not only broaden your understanding but also gain in-depth insights into the most advanced medical and surgical treatments for complex cardiovascular conditions. Equip yourself with the knowledge and skills needed to deliver the highest quality patient care in the ever-evolving field of cardiovascular medicine. Don't miss this opportunity to elevate your expertise and impact in the world of cardiology.
Learn more at the conference website!
Officially endorsed by the Heart Failure Society of America. The opinions presented in this educational activity do not necessarily reflect the opinions or recommendations of the HFSA.Target Audience
This activity is designed for clinicians, physician trainees, nurses, and other healthcare professionals across a wide range of specialties interested in applying innovative cardiovascular disease therapies to patient care.
Learning Objectives
After this activity, participants will be able to:
- Recall how to manage pulmonary hypertension in the inpatient and outpatient settings;
- Name strategies for the optimal care of post-transplant patients using evidence-based guidelines;
- Recognize how to manage advanced heart failure patients in the outpatient setting;
- Identify the current diagnostic and management strategies for common and uncommon cardiomyopathies;
- State current practice strategies of advanced practice providers in the care of heart failure patients;
- Discuss the latest scientific evidence and guidelines in acute mechanical circulatory support and cardiac transplantation;
- Explain the use of genetic testing to identify and manage heart failure patients.
| Time | Agenda | |
|---|---|---|
| 7:45 am | Breakfast / Registration | |
| 8:45 am | Introduction | Mark Anderson, MD, PhD and Gene Kim, MD |
| The Compensated Patient: Beyond GDMT | ||
| 8:50 am | CaMKII Is a Molecular Driver of Heart Failure and Arrhythmias | Mark Anderson, MD, PhD |
| 9:10 am | Case Presentation | Anthony Kanelidis, MD |
| 9:15 am | S-QUAD Therapy and Beyond: HFpEF in 2024 | Mark Belkin, MD |
| 9:30 am | Cardiac Physiological Pacing (CPP) in Heart Failure: BiV, CSP, and the Future of Resynchronization | Gaurav Upadhyay, MD |
| 9:45 am | Rise of the Machines: The Role of Devices in Advancing Heart Failure | Ben Chung, MD |
| 10:00 am | Discussion | |
| A Potpourri of Cardiomyopathy | ||
| 10:10 am | Amyloid: The Forgotten Protein | Nitasha Sarswat, MD |
| 10:25 am | Key Concepts in Recognizing and Treating Immune Checkpoint Inhibitor Myocarditis | Jeanne DeCara, MD |
| 10:40 am | Peripartum Cardiomyopathy: Diagnosis and Management of Pregnancy Related Heart Failure | Hena Patel, MD |
| 10:55 am | Discussion | |
| 11:05 am | Break | |
| Frontiers in Pulmonary Hypertension | ||
| 11:15 am | Case Presentation | Leo Gozdecki, DO |
| 11:20 am | Revealing Risk: Navigating Complexity in Pulmonary Arterial Hypertension | Stan Swat, MD |
| 11:35 am | Rapid Fire Update in Pulmonary Arterial Hypertension | Mardi Gomberg-Maitland, MD, MSc |
| 12:05 am | Pulmonary Arterial Hypertension Pharmacotherapies: Medicines That Breathe Life | Sajni Patel, PharmD |
| 12:20 am | Pulmonary Embolism 2024: Digging for Clots while we Dig for Data | Jonathan Paul, MD |
| 12:35 am | Discussion | |
| 12:45 pm | Lunch / Product Theatre |
Concurrent Breakouts
| Time | Agenda | |
|---|---|---|
| Genetics Breakout | ||
| 1:45 pm | An Introduction to Genetic Testing and the Cardiomyopathies | Rachel Campagna, MS, CGC |
| 2:00 pm | Cardiac MRI in Infiltrative Cardiomyopathy: How Can Your Friendly Imager Help? | Jeremy Slivnick, MD |
| 2:15 pm | Cardiac Myosin Inhibitor Therapy in Hypertrophic Cardiomyopathy | Gene Kim, MD |
| 2:30 pm | Discussion | |
| Nursing Breakout | ||
| 1:45 pm | Graduation, Now What?: Heart Failure Management After Medication Titration Program Completion | Rachel Lavelle, PharmD |
| 2:00 pm | The Advanced Practice Nurse Toolbox for Managing Advanced Heart Failure Patients | Alex Rivera, DNP, APRN, FNP-BC |
| 2:15 pm | Heart Transplants in the Community: Transplant Care for the Non-Transplant Professional | Cathy Murks, APN, PhD, ANP-BC |
| 2:30 pm | Discussion |
| Time | Agenda | |
|---|---|---|
| Cardiogenic Shock | ||
| 2:35 pm | Systems Under Stress: The Pathophysiology of Exercise and Shock | Sara Kalantari, MD |
| 2:50 pm | Timing and Choice of pMCS in Cardiogenic Shock | Sandeep Nathan, MD |
| 3:05 pm | The Hemodynamic Consequences of Durable Mechanical Support: Bridging the Gap to Cardiac Transplantation | Jon Grinstein, MD |
| 3:20 pm | Discussion | |
| 3:30 pm | Break | |
| Heart Transplant | ||
| 3:40 pm | HeartMate 3 or Heart Transplant: Adverse Events and Outcomes | Chris Salerno, MD |
| 3:55 pm | Expanding the Donor Pool: Shaping the Immune System for Optimal Outcomes | Ashley Loethen, PharmD |
| 4:10 pm | Transplant Considerations in the Adult with Congenital Heart Disease | Michael Earing, MD |
| 4:25 pm | New Frontiers in Heart Transplantation | Ann Nguyen, MD |
| 4:40 pm | Bloodless aCHF Surgical Therapy | Valluvan Jeevanandam, MD |
| 5:00 pm | Discussion | |
| 5:10 pm | Concluding Remarks | Ben Chung and Sara Kalantari |
*The agenda is subject to change.
David Rubenstein Forum at the University of Chicago
1201 E 60th St
Chicago, IL
60637
United States
HYBRID CONFERENCE
Participants have the opportunity to attend this activity in person or virtually. For more information about the program, contact Meeting Achievements via e-mail.
DAVID RUBENSTEIN FORUM
The David Rubenstein Forum combines a variety of spaces, both formal and informal, large and small, calm and animated, focused and diffuse, scheduled and spontaneous. Its ten-story tower features vibrant and distinct “neighborhoods.” For example, the third and fourth floors are home to Friedman Hall, a 285-seat auditorium optimized for spoken word, including keynote speeches, invited-speaker addresses, and select performances; these floors and other neighborhoods are connected by a two-story lounge. Meeting rooms on the eighth and ninth floors feature premium furnishings, finishes, and equipment, such as the Peter May Boardroom, a tiered meeting space that seats over 70. The Rubenstein Forum’s unique position on the Midway allows for expansive views toward the campus and surrounding communities as well as downtown Chicago and Lake Michigan.
VISITING CHICAGO
Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic sixth year in a row. To help plan your stay in Chicago, visit choosechicago.com.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 219-465-1115 or via email at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTORS
Sara Kalantari, MDAssistant Professor of Medicine
Director of Advanced Heart Failure Fellowship Program
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 7 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Participants Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES ARE AVAILABLE! SPACE IS LIMITED, SO SIGN UP TODAY!
This symposium offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event.
We are pleased to provide opportunities for organizations to advertise their products and services to conference participants. Whether you are sharing information about your company's products, connecting with physicians during one of the scheduled breaks, or gaining brand recognition for your company through program acknowledgments, your message will reach physicians, hematologists, pathologists, medical oncologists, trainees, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals dedicated to the treatment of hematologic cancers.
Download the prospectus 
here or contact Meeting Achievements at [email protected] or (219) 465-1115. We hope to see you there!
here or contact Meeting Achievements at [email protected] or (219) 465-1115. We hope to see you there!
REGISTRATION
After logging in/creating an account, select whether you'd like to register for in-person or virtual attendance. From there, you will initiate the registration process for your chosen mode of attendance.
| Profession Type | In-Person Fee | Virtual Fee |
|---|---|---|
| Physician | $175 | $75 |
| Healthcare Professional | $75 | $35 |
| Fellow | $50 | $0 |
| Industry | $395 | $395 |
| CANCELLATION POLICY: If you cancel your participation in this conference, your registration fee, less a 50% administrative fee, will be refunded when written notification is received by January 24, 2024. No refunds will be made after January 24, 2024. | ||
JOINING THE VIRTUAL CONFERENCE
You will receive login information from Meeting Achievements via the e-mail address used at registration 48 hours before the conference. Onsite/Day of registrants, please allow 10-15 minutes post-registration for access information to be generated.
If you need assistance joining the session or experience other technical issues, contact technical support.
If you need assistance joining the session or experience other technical issues, contact technical support.
CLAIMING CREDIT
At the end of the activity, the credit-claiming process will unlock. Choose the mode of attendance you registered for to claim credit.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
Please login or create an account to proceed.